← FDA DRUG APPROVALS

FDA ANDA · ANDA201463

DRONABINOL

Sponsor: LANNETT CO INC

APPLICATION
ANDA201463
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-18
LATEST ACTION
2021-06-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DRONABINOLDiscontinued
DRONABINOL 10MG · CAPSULE · ORAL
DRONABINOLDiscontinued
DRONABINOL 2.5MG · CAPSULE · ORAL
DRONABINOLDiscontinued
DRONABINOL 5MG · CAPSULE · ORAL

Approval history

2021-06-14Manufacturing (CMC) · Supplement 6 · standardAP
2018-05-18Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →